²é¿´: 2104  |  »Ø¸´: 5

Áîºü³å?ÛСÐÜ

ÖÁ×ðľ³æ (ÖªÃû×÷¼Ò)

ħµÀÊ¥¾ý

[½»Á÷] ¡¾2015ÄêFDAÅú×¼ÐÂÒ©»ã×Ü¡¿ ÒÑÓÐ4È˲ÎÓë

FDA Approved new Drugs in 2015


                                                                                                                                                                           date time£º2015-2-10
Cardiology/Vascular Diseases
Prestalia (perindopril arginine and amlodipine besylate); Symplmed Pharmaceuticals; For the treatment of hypertension, Approved January 2015

Savaysa (edoxaban); Daiichi Sankyo; For the treatment of deep vein thrombosis, pulmonary embolism and risk of stroke and embolism due to atrial fibrillation, Approved January 2015

Dermatology
Cosentyx (secukinumab); Novartis; For the treatment of plaque psoriasis, Approved January 2015

Endocrinology
Natpara (parathyroid hormone) ; NPS Pharmaceuticals; For the control hypocalcemia in patients with hypoparathyroidism, Approved January 2015

Family Medicine
Cosentyx (secukinumab); Novartis; For the treatment of plaque psoriasis, Approved January 2015

Savaysa (edoxaban); Daiichi Sankyo; For the treatment of deep vein thrombosis, pulmonary embolism and risk of stroke and embolism due to atrial fibrillation, Approved January 2015

Hematology
Natpara (parathyroid hormone) ; NPS Pharmaceuticals; For the control hypocalcemia in patients with hypoparathyroidism, Approved January 2015

Immunology
Cosentyx (secukinumab); Novartis; For the treatment of plaque psoriasis, Approved January 2015

Evotaz (atazanavir and cobicistat) ; Bristol-Myers Squibb; For the treatment of HIV-1 infection, Approved January 2015

Prezcobix (darunavir and cobicistat); Janssen; For the treatment of HIV-1 infection, Approved January 2015

Infections and Infectious Diseases
Bexsero (Meningococcal Group B Vaccine); Novartis; For the treatment of invasive meningococcal disease caused by serogroup B, Approved January 2015

Evotaz (atazanavir and cobicistat) ; Bristol-Myers Squibb; For the treatment of HIV-1 infection, Approved January 2015

Prezcobix (darunavir and cobicistat); Janssen; For the treatment of HIV-1 infection, Approved January 2015

Neurology
Duopa (carbidopa and levodopa) enteral suspension ; Abbvie; For the treatment of motor fluctuations in patients with advanced Parkinson's disease, Approved January 2015

Rytary (carbidopa and levodopa) extended-release capsules; Impax Labs; For the treatment of Parkinson's disease, Approved January 2015

Obstetrics/Gynecology (Women¡¯s Health)
Ibrance (palbociclib); Pfizer; For the treatment of ER-positive, HER2-negative breast cancer, Approved February 2015

Oncology
Ibrance (palbociclib); Pfizer; For the treatment of ER-positive, HER2-negative breast cancer, Approved February 2015

Pediatrics/Neonatology
Bexsero (Meningococcal Group B Vaccine); Novartis; For the treatment of invasive meningococcal disease caused by serogroup B, Approved January 2015

Vaccines
Bexsero (Meningococcal Group B Vaccine); Novartis; For the treatment of invasive meningococcal disease caused by serogroup B, Approved January 2015
»Ø¸´´ËÂ¥

» ÊÕ¼±¾ÌûµÄÌÔÌûר¼­ÍƼö

ò§çïҩѧ żµÄ

» ²ÂÄãϲ»¶

» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:

¾ý×Ó²ØÆ÷ÓÚÉí£¬´ýʱ¶ø¶¯£¡
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

³ô±¿±¿

ľ³æ (ÕýʽдÊÖ)

°ô°ô

[ ·¢×ÔÊÖ»ú°æ http://muchong.com/3g ]
2Â¥2015-02-10 19:46:47
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

ÁèÓîÀ׳Ø

³¬¼¶°æÖ÷ (ÎÄѧ̩¶·)

Сľ³æ¿ÆÑдóʹ\(^o^)/~

ÓÅÐãÇø³¤ÓÅÐãÇø³¤ÓÅÐãÇø³¤ÓÅÐãÇø³¤ÓÅÐãÇø³¤ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷

лл·ÖÏí\(^o^)/~
ÉÏÉÆÈôË®\(^o^)/~2025\(^o^)/~
3Â¥2015-02-11 08:30:25
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

myktt

ÖÁ×ðľ³æ (ÖøÃûдÊÖ)

º¢Ëûµù

лл£¬ÊÕµ½ÁË
ºÏ³ÉÀϰÖ
4Â¥2015-02-11 15:22:14
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

gatzz_0827

½ð³æ (ÕýʽдÊÖ)

¡ï
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
Ibrance (palbociclib); Pfizer; For the treatment of ER-positive, HER2-negative breast cancer, Approved February 2015
´óÅúÇÀ·Â¹«Ë¾¿ªÊ¼¼¦¶³ÁË
5Â¥2015-02-12 09:17:37
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

Áîºü³å?ÛСÐÜ

ÖÁ×ðľ³æ (ÖªÃû×÷¼Ò)

ħµÀÊ¥¾ý

ÒýÓûØÌû:
5Â¥: Originally posted by gatzz_0827 at 2015-02-12 09:17:37
Ibrance (palbociclib); Pfizer; For the treatment of ER-positive, HER2-negative breast cancer, Approved February 2015
´óÅúÇÀ·Â¹«Ë¾¿ªÊ¼¼¦¶³ÁË

¶¯×÷¿ìµÄ£¬Ó¦¸ÃÔÚÈýÆÚÁÙ´²Ê±¾Í¿ª¶¯ÁË
¾ý×Ó²ØÆ÷ÓÚÉí£¬´ýʱ¶ø¶¯£¡
6Â¥2015-02-12 09:40:05
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ Áîºü³å?ÛСÐÜ µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[ÂÛÎÄͶ¸å] ÊÛSCIÎÄÕ£¬ÎÒ:8O5.5.1.O.54,¿ÆÄ¿ÆëÈ«,¿É+¼± +3 E4V9bALS54sj 2026-09-19 3/150 2026-09-20 01:27 by 9i7PCSZyMzot
[˶²©¼ÒÔ°] ÊÛSCIÎÄÕ£¬ÎÒ:8O.5.5.1O.54,¿ÆÄ¿È«,¿ÉÊ®¼± +3 E4V9bALS54sj 2026-09-19 3/150 2026-09-20 01:27 by 9i7PCSZyMzot
[²©ºóÖ®¼Ò] ÊÛSCIÒ»ÇøT0PÎÄÕ£¬ÎÒ:8.O.55.1.O.5.4,¿ÆÄ¿È«,¿É+¼± +3 E4V9bALS54sj 2026-09-19 3/150 2026-09-20 01:15 by 9i7PCSZyMzot
[¿¼²©] ÊÛSCIÎÄÕ£¬ÎÒ:8O.5.5.1O.54,¿ÆÄ¿È«,¿ÉÊ®¼± +3 E4V9bALS54sj 2026-09-19 3/150 2026-09-20 01:03 by 9i7PCSZyMzot
[ÂÛÎÄͶ¸å] ÊÛSCIÎÄÕ£¬ÎÒ:8O5.5.1.O.54,¿ÆÄ¿ÆëÈ«,¿É+¼± +3 E4V9bALS54sj 2026-09-19 3/150 2026-09-20 00:51 by 9i7PCSZyMzot
[¿¼ÑÐ] ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8O5.5.1.O5.4,¿ÆÄ¿È«,¿ÉÙ¤¼± +3 4pRyVGCVerAA 2026-09-19 3/150 2026-09-20 00:15 by 9i7PCSZyMzot
[˶²©¼ÒÔ°] ÊÛSCI-T0PÎÄÕ£¬ÎÒ:8O.5.5.1.O.54,¿ÆÄ¿ÆëÈ«,¿É+¼± +3 4pRyVGCVerAA 2026-09-19 3/150 2026-09-20 00:03 by 9i7PCSZyMzot
[ÕÒ¹¤×÷] ÊÛSCIÒ»ÇøT0PÎÄÕ£¬ÎÒ:8.O55.1.O.54,¿ÆÄ¿È«,¿ÉÊ®¼± +4 4pRyVGCVerAA 2026-09-19 4/200 2026-09-20 00:03 by 9i7PCSZyMzot
[¿¼²©] ÊÛSCIÒ»ÇøT0PÎÄÕ£¬ÎÒ:8.O.55.1.O54,¿ÆÄ¿È«,¿ÉÙ¤¼± +3 4pRyVGCVerAA 2026-09-19 4/200 2026-09-19 23:51 by 9i7PCSZyMzot
[»ù½ðÉêÇë] ÊÛSCIÒ»ÇøT0PÎÄÕ£¬ÎÒ:8.O55.1.O.54,¿ÆÄ¿È«,¿ÉÊ®¼± +3 4pRyVGCVerAA 2026-09-19 4/200 2026-09-19 23:39 by 9i7PCSZyMzot
[¿¼ÑÐ] ÊÛSCIÒ»ÇøT0PÎÄÕ£¬ÎÒ:8.O55.1.O.54,¿ÆÄ¿È«,¿ÉÊ®¼± +3 4pRyVGCVerAA 2026-09-19 4/200 2026-09-19 23:27 by 9i7PCSZyMzot
[ÂÛÎÄͶ¸å] ÊÛSCIÒ»ÇøT0PÎÄÕ£¬ÎÒ:8.O.55.1.O54,¿ÆÄ¿È«,¿ÉÙ¤¼± +3 4pRyVGCVerAA 2026-09-19 4/200 2026-09-19 23:27 by 9i7PCSZyMzot
[¹«Åɳö¹ú] ÊÛSCIÒ»ÇøT0PÎÄÕ£¬ÎÒ:8.O.55.1.O54,¿ÆÄ¿È«,¿ÉÙ¤¼± +3 4pRyVGCVerAA 2026-09-19 4/200 2026-09-19 23:03 by 9i7PCSZyMzot
[¿¼²©] ÊÛSCIÒ»ÇøT0PÎÄÕ£¬ÎÒ:8.O.55.1.O.54,¿ÆÄ¿ÆëÈ«,¿É+¼± +3 4pRyVGCVerAA 2026-09-19 4/200 2026-09-19 23:03 by 9i7PCSZyMzot
[¹«Åɳö¹ú] ÊÛSCIÎÄÕ£¬ÎÒ:8O5.5.1.O.54,¿ÆÄ¿ÆëÈ«,¿É+¼± +3 4pRyVGCVerAA 2026-09-18 7/350 2026-09-19 21:03 by 9i7PCSZyMzot
[½Ìʦ֮¼Ò] ÏÖ´ú¡±Ñ§·§¡±¸ÃÈçºÎ½ç¶¨ +3 iaeyuan 2026-09-19 3/150 2026-09-19 20:52 by ûêdzÆÑ½
[»ù½ðÉêÇë] ¹úÉç¿ÆÏµÍ³bugÁË£¬ÊDz»ÊÇÒª·Å°ñÁË£¿ +7 kynobel 2026-09-16 9/450 2026-09-19 14:52 by ½ÓºÃÔËæÃ
[¿¼²©] É격·¢Óʼþ +8 Lmengk 2026-09-15 9/450 2026-09-19 09:27 by ÖмäÌ峬ÊÐ
[¿¼²©] ÉϺ£¹¤³Ì¼¼Êõ´óѧ¼¤¹âÖÇÄÜÖÆÔì¿ÎÌâ×é£ü2027¼¶²©Ê¿Ñо¿ÉúÕÐÉú¹«¸æ +7 ˮʿ¿Ú 2026-09-16 8/400 2026-09-16 13:47 by kkklens
[¿¼²©] ÉϺ£¹¤³Ì¼¼Êõ´óѧ¼¤¹âÖÇÄÜÖÆÔì¿ÎÌâ×éÕÐÊÕ²©Ê¿Ñо¿Éú +8 Á½ÈýËêss 2026-09-14 8/400 2026-09-16 09:46 by ˮʿ¿Ú
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û